Interpretation of tandem mass spectra of antiepileptic drugs using accurate-m/z data and m/z-shifts with stable-isotope labeled analogues

Abstract Anticonvulsant or antiepileptic drugs (AEDs) show a great structural diversity. Often, therapeutic drug monitoring (TDM) based on liquid chromatography–(tandem) mass spectrometry is applied to (individually) optimize the treatment of epilepsy and to prevent seizures. To this end, tandem-quadrupole instruments are operated in selected-reaction monitoring (SRM) mode, using one or more structure-specific product ions for the detection and quantification of the AEDs. In this study, the fragmentation in tandem mass spectrometry (MS–MS) of more than 30 antiepileptic drugs as well as more than 30 (pharmacologically relevant) metabolites is reviewed. Information on fragmentation that is scattered in the scientific literature is collected and interpreted. The identity of product ions used in SRM, i.e., elemental composition and exact-m/z, is tabulated, and more detailed fragmentation schemes and structure proposals for product ions are provided. In this way, insight is gained in the identity of the product ions used in SRM, which is a topic that is often ignored in the development of TDM methods. Moreover, this review helps in strengthening our understanding of the small-molecule fragmentation in MS–MS. In the case of AEDs, the structure proposals for the product ions can not only be confirmed with accurate-m/z data from high-resolution MS instruments, but also by studying m/z-shifts of products ions of the stable-isotope labeled analogues, that are frequently used as internal standard. For some compounds, this gives insight in the skeletal rearrangements occurring in the formation of some product ions.

• Publication year

  2020

• Venue

  International Journal of Mass Spectrometry

• Publication date

  2020-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ijms.2020.116409
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Simultaneous determination of Rivaroxaban and TAK-438 in rat plasma by LC-MS/MS: application to pharmacokinetic interaction study.

  2020cited by this paper
• Development and Validation of an UHPLC-MS/MS Assay for the Therapeutic Monitoring of Brivaracetam Plasma Concentrations in Patients with Epilepsy.

  2020cited by this paper
• Sultiame pharmacokinetic profile in plasma and erythrocytes after single oral doses: A pilot study in healthy volunteers

  2020cited by this paper
• Usefulness of saliva for perampanel therapeutic drug monitoring

  2020cited by this paper
• Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects

  2020cited by this paper
• Distribution and Chemical Analysis of Pharmaceuticals and Personal Care Products (PPCPs) in the Environmental Systems: A Review

  2019cited by this paper
• Sensitive detection of topiramate degradation products by high-performance liquid chromatography/electrospray ionization mass spectrometry using ion-pairing reagents and polarity switching.

  2019cited by this paper
• UHPLC-MS/MS method for simultaneous determination of carbamazepine and its seven major metabolites in serum of epileptic patients.

  2019cited by this paper
• LC-MS/MS-Based Quantification of 9 Antiepileptic Drugs From a Dried Sample Spot Device

  2019cited by this paper
• Analysis of 44 pharmaceuticals consumed by elderly using liquid chromatography coupled to tandem mass spectrometry

  2019cited by this paper
• Dried blood spot self-sampling by guardians of children with epilepsy is feasible: comparison with plasma for multiple antiepileptic drugs.

  2019cited by this paper
• Development and clinical applications of the dried blood spot method for therapeutic drug monitoring of anti-epileptic drugs.

  2019cited by this paper
• Fully automated therapeutic drug monitoring of anti-epileptic drugs making use of dried blood spots.

  2019cited by this paper
• Development of an online solid-phase extraction-liquid chromatography-mass spectrometric analysis of oxcarbazepine and its active metabolite licarbazepine from plasma with a direct injection step.

  2019cited by this paper
• Structure elucidation and formation mechanistic study of a methylene-bridged pregabalin dimeric degradant in pregabalin extended-release tablets.

  2019cited by this paper
• An artifactual solution degradant of pregabalin due to adduct formation with acetonitrile catalyzed by alkaline impurities during HPLC sample preparation.

  2019cited by this paper
• Validation of a High-throughput Screening and Quantification Method for the Determination of Gabapentinoids in Blood Using a Combination of LC-TOF-MS and LC-MS-MS.

  2019cited by this paper
• Fast liquid chromatography-tandem mass spectrometry method for simultaneous determination of eight antiepileptic drugs and an active metabolite in human plasma using polarity switching and timed selected reaction monitoring.

  2019cited by this paper
• A new method for simultaneous quantification of fosphenytoin, phenytoin and its primary metabolite 5-(4-hydroxyphenyl)-5-phenylhydantoin in whole blood by ultra-performance liquid chromatography-tandem mass spectrometry.

  2018cited by this paper
• Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update

  2018cited by this paper
• An Improved LC-ESI-MS/MS Method to Quantify Pregabalin in Human Plasma and Dry Plasma Spot for Therapeutic Monitoring and Pharmacokinetic Applications

  2018cited by this paper
• A simple, rapid and stability indicating validated method for quantification of lamotrigine in human plasma and dry plasma spot using LC-ESI-MS/MS: Application in clinical study.

  2018cited by this paper
• Carbamazepine, lamotrigine, levetiracetam and valproic acid in dried blood spots with liquid chromatography tandem mass spectrometry; method development and validation.

  2018cited by this paper
• Off-line solid phase extraction and liquid chromatography-tandem mass spectrometry method for the quantitation of brivaracetam acid metabolites: Method validation and application to in vitro metabolism assays.

  2018cited by this paper
• Analysis of unbound plasma concentration of oxcarbazepine and the 10‐hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers

  2018cited by this paper
• A Liquid Chromatography-Mass Spectrometry Assay for Determination of Perampanel and Concomitant Antiepileptic Drugs in the Plasma of Patients With Epilepsy Compared With a Fluorescent HPLC Assay

  2018cited by this paper
• Development of a liquid chromatography-tandem mass spectrometry method for assaying cenobamate in rat plasma

  2018cited by this paper
• A rapid and simple HPLC–MS/MS method for the simultaneous quantification of valproic acid and its five metabolites in human plasma and application to study pharmacokinetic interaction in Chinese epilepsy patients

  2018cited by this paper
• Metabolism of carbamazepine in plant roots and endophytic rhizobacteria isolated from Phragmites australis.

  2018cited by this paper
• Development and Validation of a U-HPLC-MS/MS Method for the Concurrent Measurement of Gabapentin, Lamotrigine, Levetiracetam, Monohydroxy Derivative (MHD) of Oxcarbazepine, and Zonisamide Concentrations in Serum in a Clinical Setting.

  2018cited by this paper
• Determination of carbamazepine and 12 degradation products in various compartments of an outdoor aquatic mesocosm by reliable analytical methods based on liquid chromatography-tandem mass spectrometry

  2017cited by this paper
• Comparison between dried blood spot and plasma sampling for therapeutic drug monitoring of antiepileptic drugs in children with epilepsy: A step towards home sampling.

  2017cited by this paper
• A novel LC–MS/MS method for the simultaneous quantification of topiramate and its main metabolites in human plasma

  2017cited by this paper
• UPLC-MS/MS assay for identification and quantification of brivaracetam in plasma sample: Application to pharmacokinetic study in rats.

  2017cited by this paper
• Interpretation of MS-MS Mass Spectra of Drugs and Pesticides

  2017cited by this paper
• Serum protein binding of 25 antiepileptic drugs in a routine clinical setting: A comparison of free non–protein‐bound concentrations

  2017cited by this paper
• Simultaneous UPLC-MS/MS determination of antiepileptic agents for dose adjustment.

  2017cited by this paper
• Validated Method for the Screening and Quantification of Baclofen, Gabapentin and Pregabalin in Human Post-Mortem Whole Blood Using Protein Precipitation and Liquid Chromatography-Tandem Mass Spectrometry.

  2017cited by this paper
• An LC-MS/MS based candidate reference method for the quantification of carbamazepine in human serum.

  2017cited by this paper
• Determining the Toxicological Significance of Pregabalin in Fatalities

  2017cited by this paper
• Metabolite profiling of carbamazepine and ibuprofen in Solea senegalensis bile using high-resolution mass spectrometry

  2017cited by this paper
• Simultaneous determination of four antiepileptic drugs in human plasma samples using an ultra-high-performance liquid chromatography tandem mass spectrometry method and its application in therapeutic drug monitoring.

  2016cited by this paper
• Development and validation of a sensitive UHPLC-MS/MS method for quantitation of prucalopride in rat plasma and its application to pharmacokinetics study.

  2016cited by this paper
• Comparison of piracetam measured with HPLC-DAD, HPLC-ESI-MS, DIP-APCI-MS, and a newly developed and optimized DIP-ESI-MS

  2016cited by this paper
• An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs

  2016cited by this paper
• Assessment of pharmacokinetic interaction between piracetam and l-carnitine in healthy subjects.

  2016cited by this paper
• The emerging role of multiplex tandem mass spectrometry analysis for therapeutic drug monitoring and personalized medicine

  2016cited by this paper
• Simultaneous determination of ten antiepileptic drugs in human plasma by liquid chromatography and tandem mass spectrometry with positive/negative ion-switching electrospray ionization and its application in therapeutic drug monitoring.

  2016cited by this paper
• An inter-laboratory cross-validation study for the determination of perampanel in human plasma by liquid chromatography assays.

  2016cited by this paper
• Development, validation and clinical application of an online-SPE-LC-HRMS/MS for simultaneous quantification of phenobarbital, phenytoin, carbamazepine, and its active metabolite carbamazepine 10,11-epoxide.

  2016cited by this paper
• LC-MS/MS as a tool for TDM services: Where are we?

  2016cited by this paper
• Simultaneous Determination of Valproic Acid and Its Major Metabolites by UHPLC-MS/MS in Chinese Patients: Application to Therapeutic Drug Monitoring.

  2016cited by this paper
• The use of mass spectrometry to analyze dried blood spots.

  2016cited by this paper
• Determination of a selection of anti-epileptic drugs and two active metabolites in whole blood by reversed phase UPLC-MS/MS and some examples of application of the method in forensic toxicology cases.

  2015cited by this paper
• Advances in high‐resolution accurate mass spectrometry application to targeted proteomics

  2015cited by this paper
• A LC-MS/MS method for therapeutic drug monitoring of carbamazepine, lamotrigine and valproic acid in DBS.

  2015cited by this paper
• High-performance liquid chromatography-tandem mass spectrometry method for the determination of perampanel, a novel α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist in human plasma.

  2015cited by this paper
• Quantification of new antiepileptic drugs by liquid chromatography/electrospray ionization tandem mass spectrometry and its application to cellular uptake experiment using human placental choriocarcinoma BeWo cells.

  2015cited by this paper
• Multiplex Mass Spectrometry Analysis of Latest-Generation Antiepileptic Drugs: A Clinically Useful Laboratory Tool for Improved Real-Time Patients' Care

  2015cited by this paper
• Dried blood spot assay for the quantification of phenytoin using Liquid Chromatography-Mass Spectrometry.

  2015cited by this paper
• Therapeutic drug monitoring of carbamazepine and its metabolite in children from dried blood spots using liquid chromatography and tandem mass spectrometry.

  2015cited by this paper
• Development of a SPE-HPLC-MS/MS method for the determination of most prescribed pharmaceuticals and related metabolites in urban sewage samples.

  2015cited by this paper
• LC-QTOF MS screening of more than 1,000 licit and illicit drugs and their metabolites in wastewater and surface waters from the area of Bogotá, Colombia

  2015cited by this paper
• Topiramate: a review of analytical approaches for biological matrices.

  2015cited by this paper
• Analysis and advanced oxidation treatment of a persistent pharmaceutical compound in wastewater and wastewater sludge-carbamazepine.

  2014cited by this paper
• Simultaneous analysis of 22 antiepileptic drugs in postmortem blood, serum and plasma using LC-MS-MS with a focus on their role in forensic cases.

  2014cited by this paper
• Quantification of pregabalin using hydrophilic interaction HPLC-high-resolution MS in postmortem human samples: eighteen case reports.

  2014cited by this paper
• Screening and quantitative determination of drugs of abuse in diluted urine by UPLC-MS/MS.

  2014cited by this paper
• Determination of 81 pharmaceutical drugs by high performance liquid chromatography coupled to mass spectrometry with hybrid triple quadrupole-linear ion trap in different types of water in Serbia.

  2014cited by this paper
• Development and Validation of a Simple and Reliable LC-MS/MS Method for the Determination of Acetazolamide, an Effective Carbonic Anhydrase Inhibitor, in Plasma and its Application to a Pharmacokinetic Study

  2014cited by this paper
• Appendix Q

  2013cited by this paper
• Chronic, low concentration exposure to pharmaceuticals impacts multiple organ systems in zebrafish.

  2013cited by this paper
• Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study.

  2013cited by this paper
• Liquid chromatography-mass spectrometric determination of rufinamide in low volume plasma samples.

  2013cited by this paper
• Fully validated method for rapid and simultaneous measurement of six antiepileptic drugs in serum and plasma using ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry.

  2013cited by this paper
• Development and validation of dried blood spots technique for quantitative determination of topiramate using liquid chromatography-tandem mass spectrometry.

  2013cited by this paper
• Principles and Current Issues of Antiepileptic Drug Therapy

  2013cited by this paper
• Consumption and occurrence of pharmaceutical and personal care products in the aquatic environment in Spain.

  2013cited by this paper
• Degradation of carbamazepine by Trametes versicolor in an air pulsed fluidized bed bioreactor and identification of intermediates.

  2012cited by this paper
• Detection of 22 antiepileptic drugs by ultra-performance liquid chromatography coupled with tandem mass spectrometry applicable to routine therapeutic drug monitoring.

  2012cited by this paper
• Identification of tiagabine degradation products using liquid chromatography with electrospray ionization multistage mass spectrometry and ultra-performance liquid chromatography/high-resolution mass spectrometry.

  2012cited by this paper
• Liquid chromatography tandem mass spectrometry method for the estimation of lamotrigine in human plasma: Application to a pharmacokinetic study

  2012cited by this paper
• Successful and cost-efficient replacement of immunoassays by tandem mass spectrometry for the quantification of immunosuppressants in the clinical laboratory.

  2012cited by this paper
• Identification of the unknown transformation products derived from clarithromycin and carbamazepine using liquid chromatography/high-resolution mass spectrometry.

  2012cited by this paper
• High-Performance Liquid Chromatography–Tandem Mass Spectrometry Method for Simultaneous Quantification of Carbamazepine, Oxcarbazepine, and Their Main Metabolites in Human Serum

  2012cited by this paper
• Identification and characterization of four process-related impurities in retigabine.

  2012cited by this paper
• Rapid and sensitive LC-MS/MS method for quantification of lamotrigine in human plasma: application to a human pharmacokinetic study.

  2012cited by this paper
• Evaluation of carbamazepine uptake and metabolization by Typha spp., a plant with potential use in phytotreatment.

  2011cited by this paper
• It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS.

  2011cited by this paper
• Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography/tandem mass spectrometry.

  2011cited by this paper
• Rapid assay of rufinamide in dried blood spots by a new liquid chromatography-tandem mass spectrometric method.

  2011cited by this paper
• Degradation of aqueous carbamazepine in ultrasonic/Fe0/H2O2 systems

  2011cited by this paper
• Development and validation of a reference measurement procedure for certification of phenytoin, phenobarbital, lamotrigine, and topiramate in human serum using isotope-dilution liquid chromatography/tandem mass spectrometry

  2011cited by this paper
• Determination of pharmaceuticals, steroid hormones, and endocrine-disrupting personal care products in sewage sludge by ultra-high-performance liquid chromatography–tandem mass spectrometry

  2011cited by this paper
• Quantification of carbamazepine and atrazine and screening of suspect organic contaminants in surface and drinking waters.

  2011cited by this paper
• Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MS(E) accurate-mass spectra.

  2011cited by this paper
• Development and validation of an enantioselective liquid-chromatography/tandem mass spectrometry method for the separation and quantification of eslicarbazepine acetate, eslicarbazepine, R-licarbazepine and oxcarbazepine in human plasma.

  2011cited by this paper
• LC-MS/MS method for simultaneous determination of valproic acid and major metabolites in human plasma.

  2011cited by this paper
• Analyte and internal standard cross signal contributions and their impact on quantitation in LC-MS based bioanalysis.

  2011cited by this paper
• Rapid ultraperformance liquid chromatography-tandem mass spectrometry method for quantification of oxcarbazepine and its metabolite in human plasma.

  2011cited by this paper

• Advances in sample preparation techniques combined with analytical methods for the determination of antiepileptic drugs (AEDs)

  2025cites this paper
• Laser Secondary Neutral Mass Spectrometry of Bi3+ Sputtered Pharmaceuticals.

  2025cites this paper
• Therapeutic Salivary Monitoring of Perampanel in Patients with Epilepsy Using a Volumetric Absorptive Microsampling Technique

  2023cites this paper
• Interpretation of MS–MS spectra of small-molecule signal transduction inhibitors using accurate-m/z data and m/z-shifts with stable-isotope-labeled analogues and metabolites

  2021cites this paper
• Tandem mass spectrometry of organic nitro and halogen compounds: Competition between losses of molecules and of radicals

  2020cites this paper